Integra LifeSciences
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are...
Latest News
6 days ago · seekingalpha.com
Integra LifeSciences Holdings Corporation (IART) Presents at 2026 UBS Global Healthcare Conference TranscriptIntegra LifeSciences Holdings Corporation (IART) Presents at 2026 UBS Global Healthcare Conference Transcript
26 days ago · seekingalpha.com
Integra LifeSciences Holdings Corporation (IART) Q3 2026 Earnings Call TranscriptIntegra LifeSciences Holdings Corporation (IART) Q3 2026 Earnings Call Transcript
27 days ago · fool.com
Integra: 3 Key Takeaways for Long-Term InvestorsOperating cash flow hit a record even as the company navigates supply disruptions, a sign of underlying business resilience.
27 days ago · marketbeat.com
What Integra LifeSciences (IART) Said on Its Q3 Earnings CallIntegra LifeSciences NASDAQ: IART reported third-quarter revenue at the low end of its guidance range as a flooding-related disruption at its Cincinnati facility and slower-than-expected Tissue Reconstruction performance weighed on results. The company said strength in neurosurgery and international Specialty Surgery partially offset those pressures.
27 days ago · zacks.com
Integra (IART) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesAlthough the revenue and EPS for Integra (IART) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
27 days ago · zacks.com
Integra LifeSciences (IART) Surpasses Q3 Earnings EstimatesIntegra LifeSciences (IART) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.54 per share a year ago.
27 days ago · globenewswire.com
Integra LifeSciences Reports Third Quarter 2026 Financial ResultsPRINCETON, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2026.
28 days ago · globenewswire.com
Integra Announces Completion of Refinancing TransactionsPRINCETON, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced that it has closed a private offering of $450.0 million aggregate principal amount of 9.500% senior secured notes due 2033 (the “Notes”).
1 month ago · globenewswire.com
Integra LifeSciences to Highlight ENT and Instruments Portfolios and Sponsor New Clinical Research Presentations at AAO-HNSF 2026 Annual MeetingPRINCETON, N.J., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a global leader in medical technology, today announced its participation in the 2026 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, taking place October 17-20 in Los Angeles, California.
1 month ago · gurufocus.com
A Look at Integra Lifesciences Holdings Corp (IART) After 3.1% Gain -- GF Value $20.47 vs Price $13.41On October 08, 2026, Integra Lifesciences Holdings Corp (IART) shares rose 3.1% to a current price of $13.41. This price remains significantly below its 52-week
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove IART